Agfa sells CardioNow

Agfa sells CardioNow
A provider of data management  services for clinical trials has purchased CardioNow from Agfa Healthcare. With this acquisition, BioClinica plans to add within 45 days the ability to track, share, blindly interpret, and archive medical images for multi-center clinical trials to its services portfolio. Neither the price of the acquisition nor other details regarding the acquisition were publicly released.  Executives at BioClinica expect to integrate CardioNow services  into their portfolio, extending the company’s ability to manage the process that begins after a medical image is acquired as part of a clinical trial. Imaging information will also be integrated with BioClinica Express electronic data capture to simplify and enhance the clinical trial process for life science companies, according to BioClinica.